SICRF yields 1.06% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SICRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SICRF + PFE for your $10,000?
SimCorp A/S, together with its subsidiaries, provides investment management solutions for asset management, fund management, insurance, life/pension, central banks, asset servicing, treasury, sovereign wealth, and wealth management companies. It provides SimCorp Dimension, an integrated front-to-back investment management solution; SimCorp Sofia, a front-to-back investment management solution for the Italian insurance market; SimCorp Gain, an enterprise data management solution for reference and market data management; and SimCorp Coric, a solution for client communications and reporting automation. The company also offers front office solutions, including asset, alternative investment, order, and compliance manager; and back office solutions comprising settlement, corporate actions, cash and securities, investment accounting, collateral, general ledger, and fund administration manager. In addition, it provides middle office solutions consisting of strategy, risk analysis, and performance manager; and data and reporting solutions, which include client communications, data warehouse manager, reconciliation, and enterprise data manager. The company has operations in North America, Europe, the Middle East, Africa, and the Asia Pacific. SimCorp A/S was founded in 1971 and is headquartered in Copenhagen, Denmark.
Full SICRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.